268 related articles for article (PubMed ID: 32281421)
21. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in
Colini Baldeschi A; Pittaluga E; Andreola F; Rossi S; Cozzolino M; Nicotera G; Sferrazza G; Pierimarchi P; Serafino A
Front Aging Neurosci; 2018; 10():20. PubMed ID: 29449807
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming energetic metabolism in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
[TBL] [Abstract][Full Text] [Related]
23. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway.
Zhang G; Ge M; Han Z; Wang S; Yin J; Peng L; Xu F; Zhang Q; Dai Z; Xie L; Li Y; Si J; Ma K
Biomed Pharmacother; 2019 Feb; 110():420-430. PubMed ID: 30530044
[TBL] [Abstract][Full Text] [Related]
24. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
25. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
26. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
27. Wnt signaling: role in LTP, neural networks and memory.
Oliva CA; Vargas JY; Inestrosa NC
Ageing Res Rev; 2013 Jun; 12(3):786-800. PubMed ID: 23665425
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.
Berwick DC; Javaheri B; Wetzel A; Hopkinson M; Nixon-Abell J; Grannò S; Pitsillides AA; Harvey K
Mol Neurodegener; 2017 Jan; 12(1):9. PubMed ID: 28103901
[TBL] [Abstract][Full Text] [Related]
29. A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.
Salašová A; Yokota C; Potěšil D; Zdráhal Z; Bryja V; Arenas E
Mol Neurodegener; 2017 Jul; 12(1):54. PubMed ID: 28697798
[TBL] [Abstract][Full Text] [Related]
30. How Wnt Signaling Builds the Brain: Bridging Development and Disease.
Noelanders R; Vleminckx K
Neuroscientist; 2017 Jun; 23(3):314-329. PubMed ID: 27624848
[TBL] [Abstract][Full Text] [Related]
31. Remarkable impairment of Wnt/β-catenin signaling in the brains of the mice infected with scrapie agents.
Sun J; Wang H; Chen LN; Wang J; Lv Y; Yang XD; Zhang BY; Tian C; Shi Q; Dong XP
J Neurochem; 2016 Feb; 136(4):731-740. PubMed ID: 26526056
[TBL] [Abstract][Full Text] [Related]
32. Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling.
Giovannini D; Andreola F; Spitalieri P; Krasnowska EK; Colini Baldeschi A; Rossi S; Sangiuolo F; Cozzolino M; Serafino A
Cell Death Discov; 2021 Nov; 7(1):330. PubMed ID: 34725335
[TBL] [Abstract][Full Text] [Related]
33. Wnt/β-catenin signaling in Alzheimer's disease.
De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
[TBL] [Abstract][Full Text] [Related]
34. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Verma MK; Goel R; Krishnadas N; Nemmani KVS
Expert Opin Ther Targets; 2018 Jul; 22(7):615-628. PubMed ID: 29911915
[TBL] [Abstract][Full Text] [Related]
35. Wnt signalling pathway and tau phosphorylation: A comprehensive study on known connections.
Hadi F; Akrami H; Shahpasand K; Fattahi MR
Cell Biochem Funct; 2020 Aug; 38(6):686-694. PubMed ID: 32232872
[TBL] [Abstract][Full Text] [Related]
36. L-carnitine contributes to enhancement of neurogenesis from mesenchymal stem cells through Wnt/β-catenin and PKA pathway.
Fathi E; Farahzadi R; Charoudeh HN
Exp Biol Med (Maywood); 2017 Mar; 242(5):482-486. PubMed ID: 28056548
[TBL] [Abstract][Full Text] [Related]
37. Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.
Zhou Y; Wang T; Hamilton JL; Chen D
Curr Rheumatol Rep; 2017 Sep; 19(9):53. PubMed ID: 28752488
[TBL] [Abstract][Full Text] [Related]
38. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
[TBL] [Abstract][Full Text] [Related]
39. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
